GSK intends to completely offload Haleon shares
LONDON, UK: GSK plc (LSE/NYSE: GSK) it intends to sell approximately 385 million ordinary shares in Haleon, equivalent to approximately 4.2% of Haleon’s issued share capital and representing GSK’s entire shareholding in Haleon. Following the successful demerger and premium listing…